Sector News

ICL to sell pharma, cosmetics and gypsum businesses to One Rock Capital Partners

May 26, 2015
Energy & Chemical Value Chain
Israel Chemicals Ltd. (ICL; Tel Aviv) says that its performance products segment has agreed to sell the company’s Germany-based pharmaceutical, cosmetics and gypsum (PCG) businesses to an affiliate of One Rock Capital Partners (New York), a private equity firm active in the chemicals industry. The share and asset purchase agreement is expected to close in the near term, ICL says. Financial details of the deal have not been disclosed. ICL’s PCG business units are engaged in the production of active ingredients for antacids and antiperspirants, as well as products for dental applications. The sale of the PCG business units is part of ICL’s strategy to divest its non-core businesses to focus on its core businesses in the agriculture, food and engineered materials markets and to optimize its positioning in those markets. As part of the strategy to divest non-core businesses, ICL, earlier this year, completed the sale of its businesses that produce alumina compounds, paper chemicals, and water treatment chemicals to Kurita Water Industries (Tokyo), Japan’s leading water treatment company, for €250 million ($272 million). Last December, ICL also agreed to sell its Rhenoflex business unit based at Ludwigshafen and in China to Findos Investor (Munich), an independent, midmarket private equity fund. Rhenoflex is a leading supplier of high-end shoe reinforcement materials and orthopedic parts to leading brands in the global footwear industry.
 
One Rock’s purchase of the PCG businesses is in line with its investment strategy and will provide One Rock with an opportunity to expand its activities in the global chemicals industry, ICL says.
 
 “ICL performance products intends to use the proceeds from the sale of our PCG businesses to strengthen our core businesses in the food and engineered materials markets, and to expand our global presence, especially in emerging markets,” says ICL performance products segment’s president and CEO, Mark Volmer. “We are certain that we have found an optimal owner for our PCG units that will develop their businesses and increase their activities globally,” Volmer says.
 
Earlier this year, One Rock Capital purchased a stake in Compass Chemical (Smyrna, GA), a maker of organophosphates, for an undisclosed amount.
 
By Deepti Ramesh
 

comments closed

Related News

June 22, 2024

Vynova announces R&D programme on PVC recycling technologies

Energy & Chemical Value Chain

Vynova announced the launch of a research & development programme to further advance PVC recycling and help the PVC value chain accelerate towards circularity. Vynova’s innovation efforts focus on technologies to remove heavy metals from dissolved rigid post-consumer PVC waste such as used window profiles or pipes.

June 22, 2024

Actylis appoints Scott Thomson as CEO

Energy & Chemical Value Chain

Actylis, a global manufacturer and sourcing expert of critical materials and performance ingredients for the life sciences and specialty chemicals markets formed in 2022, appointed Scott Thomson as new Chief Executive Officer. Scott Thomson, who succeeds Gilles Cottier at the helm of the Port Washington, NY-based CDMO, has a three-decade track record in the pharmaceutical and chemical industries.

June 22, 2024

ADM and Bayer expand regenerative agriculture partnership

Energy & Chemical Value Chain

ADM and Bayer have announced an extension of their regenerative agriculture collaboration, working with farmers to lower carbon emissions across Europe. The companies embarked on a feasibility study last year to evaluate regenerative agriculture practices’ impact on curbing carbon emissions, increasing biodiversity and improving soil health.

How can we help you?

We're easy to reach